Druggable molecular alterations in bile duct cancer: potential and current therapeutic applications in clinical trials-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Druggable molecular alterations in bile duct cancer: potential and current therapeutic applications in clinical trials

Published:2021-08-22 Issue:9 Volume:30 Page:975-983
ISSN:1354-3784
Container-title:Expert Opinion on Investigational Drugs
language:en
Short-container-title:Expert Opinion on Investigational Drugs

Author:

Bourien Héloïse¹,Lamarca Angela²,McNamara Mairéad G³,Hubner Richard A²,Valle Juan W³,Edeline Julien¹^ORCID

Affiliation:

1. Department Of Medical Oncology, Centre Eugène Marquis, Rennes, France, France

2. Department Of Medical Oncology, The Christie Nhs Foundation Trust/Division Of Cancer Sciences, University Of Manchester, Manchester, UK

3. Division Of Cancer Sciences, University Of Manchester/Department Of Medical Oncology, The Christie Nhs Foundation Trust, Manchester, UK

Funder

This paper is not funded

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/13543784.2021.1964470

Reference74 articles.

1. Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract Cancer

2. Gemcitabine alone or in combination with cisplatin in patients with biliary tract cancer: a comparative multicentre study in Japan

3. Cisplatin and gemcitabine for advanced biliary tract cancer: a meta-analysis of two randomised trials

4. Second-line FOLFOX chemotherapy versus active symptom control for advanced biliary tract cancer (ABC-06): a phase 3, open-label, randomised, controlled trial

5. Precision medicine for patients with advanced biliary tract cancers: An effective strategy within the prospective MOSCATO-01 trial

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeted Therapy with Polymeric Nanoparticles in PBRM1-Mutant Biliary Tract Cancers: Harnessing DNA Damage Repair Mechanisms;Critical Reviews in Oncology/Hematology;2024-09

2. Exploring the Promise of Second-Line Chemotherapy in Biliary Tract Tumours: A Glimpse into Novel Treatment Approaches;Cancers;2023-11-23

3. Chemotherapy with or without selective internal radiation therapy for intrahepatic cholangiocarcinoma: Data from clinical trials;Hepatology;2023-07-25

4. Cholangiocarcinoma: Pathologic and Molecular Classification in the Era of Precision Medicine;Archives of Pathology & Laboratory Medicine;2023-06-19

5. Practicalities accessing precision medicine in biliary tract cancer;The Lancet Gastroenterology & Hepatology;2023-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3